PDF Part VI: Summary of the risk management plan - Lægemiddelstyrelsen
3
0
0
Texto
Documentos relacionados
Risk Management Plan Page 12/13 II.A List of important risks and missing information Important risks of Icatibant AdAlvo 30 mg/3 ml injektionsvæske, opløsning are risks that need
